These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16411036)

  • 21. Evaluation of Neuropsychiatric Function in Phenylketonuria: Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria.
    Wyrwich KW; Auguste P; Yu R; Zhang C; Dewees B; Winslow B; Yu S; Merilainen M; Prasad S
    Value Health; 2015 Jun; 18(4):404-12. PubMed ID: 26091594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emotional symptoms and their contribution to functional impairment in adults with attention-deficit/hyperactivity disorder.
    Mörstedt B; Corbisiero S; Bitto H; Stieglitz RD
    Atten Defic Hyperact Disord; 2016 Mar; 8(1):21-33. PubMed ID: 26254914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
    Manor I; Ben-Hayun R; Aharon-Peretz J; Salomy D; Weizman A; Daniely Y; Megiddo D; Newcorn JH; Biederman J; Adler LA
    J Clin Psychiatry; 2012 Dec; 73(12):1517-23. PubMed ID: 23290324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive behavioral therapy for adults with attention-deficit hyperactivity disorder: study protocol for a randomized controlled trial.
    Huang F; Qian Q; Wang Y
    Trials; 2015 Apr; 16():161. PubMed ID: 25873090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents.
    Adler LA; Shaw DM; Spencer TJ; Newcorn JH; Hammerness P; Sitt DJ; Minerly C; Davidow JV; Faraone SV
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):238-44. PubMed ID: 22537184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional outcomes in the treatment of adults with ADHD.
    Adler LA; Spencer TJ; Levine LR; Ramsey JL; Tamura R; Kelsey D; Ball SG; Allen AJ; Biederman J
    J Atten Disord; 2008 May; 11(6):720-7. PubMed ID: 17968028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attention-deficit/hyperactivity disorder in childhood/adolescence and impairments associated with daily life: French data from the European Lifetime Impairment Survey].
    Caci H; Paillé S
    Arch Pediatr; 2014 Dec; 21(12):1283-92. PubMed ID: 25300717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning.
    Wietecha L; Young J; Ruff D; Dunn D; Findling RL; Saylor K
    Clin Neuropharmacol; 2012; 35(3):125-33. PubMed ID: 22561876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Impairment Mediates the Relationship Between Adult ADHD Inattentiveness and Occupational Outcome.
    Gjervan B; Hjemdal O; Nordahl HM
    J Atten Disord; 2016 Jun; 20(6):510-8. PubMed ID: 23407280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quick Delay Questionnaire: Reliability, validity, and relations to functional impairments in adults with attention-deficit/hyperactivity disorder (ADHD).
    Thorell LB; Sjöwall D; Mies GW; Scheres A
    Psychol Assess; 2017 Oct; 29(10):1261-1272. PubMed ID: 27991822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention-deficit/hyperactivity disorder symptoms, adaptive functioning, and quality of life in children with autism spectrum disorder.
    Sikora DM; Vora P; Coury DL; Rosenberg D
    Pediatrics; 2012 Nov; 130 Suppl 2():S91-7. PubMed ID: 23118259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life and psychomotor profile of children with attention deficit hyperactivity disorder (ADHD).
    Goulardins JB; Marques JC; Casella EB
    Arq Neuropsiquiatr; 2011 Aug; 69(4):630-5. PubMed ID: 21877032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of a new measure of quality of life for young people with diabetes mellitus: the ADDQoL-Teen.
    McMillan CV; Honeyford RJ; Datta J; Madge NJ; Bradley C
    Health Qual Life Outcomes; 2004 Nov; 2():61. PubMed ID: 15535888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems.
    Mautner VF; Granström S; Leark RA
    J Atten Disord; 2015 Jan; 19(1):35-43. PubMed ID: 22786884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring quality of life in adults with ADHD: reliability and validity of a new measure.
    Landgraf JM
    J Atten Disord; 2007 Nov; 11(3):351-62. PubMed ID: 17494834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further Validation of the Conner's Adult Attention Deficit/Hyperactivity Rating Scale Infrequency Index (CII) for Detection of Non-Credible Report of Attention Deficit/Hyperactivity Disorder Symptoms.
    Cook CM; Bolinger E; Suhr J
    Arch Clin Neuropsychol; 2016 Jun; 31(4):358-64. PubMed ID: 27193367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention-deficit/hyperactivity disorder symptoms and loneliness among adults in the general population.
    Stickley A; Koyanagi A; Takahashi H; Ruchkin V; Kamio Y
    Res Dev Disabil; 2017 Mar; 62():115-123. PubMed ID: 28131008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder.
    Weiss MD; Gibbins C; Goodman DW; Hodgkins PS; Landgraf JM; Faraone SV
    J Clin Psychiatry; 2010 Apr; 71(4):381-90. PubMed ID: 20361900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.
    Durell TM; Adler LA; Williams DW; Deldar A; McGough JJ; Glaser PE; Rubin RL; Pigott TA; Sarkis EH; Fox BK
    J Clin Psychopharmacol; 2013 Feb; 33(1):45-54. PubMed ID: 23277268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.